Sean McCutcheon
Stock Analyst at Raymond James
(n/a)
# 4,268
Out of 4,944 analysts
9
Total ratings
11.11%
Success rate
-30.56%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VIR Vir Biotechnology | Initiates: Outperform | $12 | $4.57 | +162.58% | 1 | Jul 11, 2025 | |
| JANX Janux Therapeutics | Initiates: Outperform | $65 | $24.96 | +160.42% | 1 | Jul 11, 2025 | |
| CMPX Compass Therapeutics | Reinstates: Outperform | $9 | $3.10 | +190.32% | 1 | Jul 1, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Outperform | $11 | $2.77 | +297.11% | 1 | Jul 1, 2025 | |
| ENGN enGene Holdings | Initiates: Outperform | $23 | $3.68 | +525.00% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $7.72 | +418.13% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $36.88 | +89.80% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $36.93 | +132.87% | 1 | Mar 13, 2024 |
Vir Biotechnology
Jul 11, 2025
Initiates: Outperform
Price Target: $12
Current: $4.57
Upside: +162.58%
Janux Therapeutics
Jul 11, 2025
Initiates: Outperform
Price Target: $65
Current: $24.96
Upside: +160.42%
Compass Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $9
Current: $3.10
Upside: +190.32%
Black Diamond Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $11
Current: $2.77
Upside: +297.11%
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $3.68
Upside: +525.00%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $7.72
Upside: +418.13%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $36.88
Upside: +89.80%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $36.93
Upside: +132.87%